Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Medical Genetics

Is Autosomal Dominant Optic Atrophy Inherited?

At a Glance

Yes, Autosomal Dominant Optic Atrophy (ADOA) is an inherited condition typically caused by an OPA1 gene mutation. If you have this mutation, there is a 50% chance of passing it to each child. A genetic counselor can help explore family planning options like Preimplantation Genetic Testing (PGT).

Yes, as the name suggests, Autosomal Dominant Optic Atrophy (ADOA) is an inherited condition [1]. The most common cause is a mutation in a gene called OPA1 [1][2]. If your ADOA is caused by this mutation, there is a 50% chance of passing the mutated gene to each of your children [3]. This chance is exactly the same for every pregnancy, regardless of whether the child is male or female [3].

How Autosomal Dominant Inheritance Works

We inherit our genes in pairs—one from each biological parent. The term autosomal dominant means:

  • Autosomal: The gene is located on one of the non-sex chromosomes. Because it is not tied to the X or Y chromosomes, males and females are equally likely to inherit the mutation and pass it on [3].
  • Dominant: You only need one copy of the mutated gene (out of the pair) to have the condition [1].

If your ADOA is caused by an OPA1 mutation, one copy of your OPA1 gene has a mutation, and the other copy works normally. When you have a child, you randomly pass on one of these two genes. Therefore, there is a 1 in 2 (50%) chance your child will inherit the gene with the mutation, and a 1 in 2 (50%) chance they will inherit the typical gene [3].

Unpredictable Symptoms

Even if a child inherits the ADOA mutation, it is difficult to predict exactly how they will be affected. The severity of symptoms can look very different from person to person, even within the same family [4][1].

  • Vision changes typically begin during childhood [5][6]. Some people may have very mild vision changes, while others experience more significant vision loss [7][8].
  • A smaller group of people with ADOA develop what is known as “ADOA plus,” which involves extra symptoms beyond vision loss, such as hearing loss, muscle weakness, or balance issues [9][7]. These additional symptoms vary widely, and many individuals with the OPA1 mutation will only ever experience vision changes [9].

Care for Existing Children

If you already have children and have recently been diagnosed, it is natural to worry about their health. Because ADOA symptoms typically begin in childhood [5], it is a good idea to have your children evaluated by a pediatric eye doctor (ophthalmologist).

The eye doctor can check their visual acuity and perform specialized scans of the retina and optic nerve to establish a baseline and monitor for early changes [10][11]. You can also discuss with a genetic counselor whether it makes sense to pursue genetic testing for your children to see if they carry the family’s specific OPA1 mutation [2][12].

Family Planning and Genetic Counseling

Because ADOA is passed down through families, it is highly recommended to work with a genetic counselor. A genetic counselor is a healthcare professional trained to help you understand your genetic risks and family planning options.

If you are thinking about having children and want to prevent passing on the mutated gene, your genetic counselor can discuss options such as Preimplantation Genetic Testing (PGT) [13].

PGT is a specialized procedure used during in vitro fertilization (IVF). It allows doctors to test embryos for the specific genetic mutation that causes ADOA before the embryo is transferred to the uterus [13]. In order to use PGT, the specific genetic mutation causing ADOA in your family must first be identified through genetic testing [2][14].

Because PGT is an advanced and sometimes costly procedure, your genetic counselor can guide you through the medical, financial, and emotional aspects to help set realistic expectations. They can also discuss other family planning options with you, ensuring you can make the choice that feels right for your family.

Common questions in this guide

Is autosomal dominant optic atrophy passed down to children?
Yes, ADOA is an inherited condition usually caused by a mutation in the OPA1 gene. Because it is an autosomal dominant condition, a parent with the mutation has a 50% chance of passing it to each of their children, regardless of the child's sex.
If my child inherits the ADOA gene, will they lose their vision?
Symptoms of ADOA are very difficult to predict and can vary widely, even within the same family. Some children who inherit the gene may experience very mild vision changes, while others may face more significant vision loss.
What is ADOA plus?
ADOA plus is a less common form of the condition where individuals experience extra symptoms beyond vision loss. These additional symptoms can include hearing loss, muscle weakness, and balance issues.
Can I prevent passing ADOA to my future children?
Yes, there are family planning options to help prevent passing the mutated gene to future children. Working with a genetic counselor, you can explore procedures like Preimplantation Genetic Testing (PGT) during IVF, which tests embryos for the specific ADOA mutation before pregnancy.
When should my children be tested for ADOA?
Because vision changes from ADOA typically begin during childhood, you should have your children evaluated by a pediatric ophthalmologist. The eye doctor can check their vision and take scans of the retina and optic nerve to establish a baseline and monitor for early changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific genetic mutation was identified in my genetic testing, and can I have a copy of the report for my records?
  2. 2.At what age should my existing children have their first comprehensive eye exam to check for signs of ADOA?
  3. 3.Can you refer me to a genetic counselor who specializes in inherited eye diseases?
  4. 4.Are there specific signs of 'ADOA plus' that I should be monitoring myself or my children for?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    ATPase Domain AFG3L2 Mutations Alter OPA1 Processing and Cause Optic Neuropathy.

    Caporali L, Magri S, Legati A, et al.

    Annals of neurology 2020; (88(1)):18-32 doi:10.1002/ana.25723.

    PMID: 32219868
  2. 2

    Mutation spectrum of the OPA1 gene in a large cohort of patients with suspected dominant optic atrophy: Identification and classification of 48 novel variants.

    Weisschuh N, Schimpf-Linzenbold S, Mazzola P, et al.

    PloS one 2021; (16(7)):e0253987 doi:10.1371/journal.pone.0253987.

    PMID: 34242285
  3. 3

    Exome sequencing identified a novel de novo OPA1 mutation in a consanguineous family presenting with optic atrophy.

    Cohen L, Tzur S, Goldenberg-Cohen N, et al.

    Genetics research 2016; (98()):e10 doi:10.1017/S0016672316000070.

    PMID: 27265430
  4. 4

    Visual Function and Inner Retinal Structure in Relation to Birth Factors in Autosomal Dominant Optic Atrophy.

    Eckmann-Hansen C, Bek T, Sander B, Larsen M

    Investigative ophthalmology & visual science 2023; (64(10)):32 doi:10.1167/iovs.64.10.32.

    PMID: 37498569
  5. 5

    A novel AFG3L2 mutation close to AAA domain leads to aberrant OMA1 and OPA1 processing in a family with optic atrophy.

    Baderna V, Schultz J, Kearns LS, et al.

    Acta neuropathologica communications 2020; (8(1)):93 doi:10.1186/s40478-020-00975-w.

    PMID: 32600459
  6. 6

    Genetic and Clinical Analyses of DOA and LHON in 304 Chinese Patients with Suspected Childhood-Onset Hereditary Optic Neuropathy.

    Li Y, Li J, Jia X, et al.

    PloS one 2017; (12(1)):e0170090 doi:10.1371/journal.pone.0170090.

    PMID: 28081242
  7. 7

    Meta-analysis of genotype-phenotype analysis of OPA1 mutations in autosomal dominant optic atrophy.

    Ham M, Han J, Osann K, et al.

    Mitochondrion 2019; (46()):262-269 doi:10.1016/j.mito.2018.07.006.

    PMID: 30165240
  8. 8

    Not only dominant, not only optic atrophy: expanding the clinical spectrum associated with OPA1 mutations.

    Nasca A, Rizza T, Doimo M, et al.

    Orphanet journal of rare diseases 2017; (12(1)):89 doi:10.1186/s13023-017-0641-1.

    PMID: 28494813
  9. 9

    Autosomal dominant optic atrophy plus due to the novel OPA1 variant c.1463G>C.

    Finsterer J, Laccone F

    Metabolic brain disease 2019; (34(4)):1023-1027 doi:10.1007/s11011-019-00425-0.

    PMID: 31152339
  10. 10

    Thickness mapping of individual retinal layers and sectors by Spectralis SD-OCT in Autosomal Dominant Optic Atrophy.

    Corajevic N, Larsen M, Rönnbäck C

    Acta ophthalmologica 2018; (96(3)):251-256 doi:10.1111/aos.13588.

    PMID: 29091347
  11. 11

    Genotype-phenotype heterogeneity of ganglion cell and inner plexiform layer deficit in autosomal-dominant optic atrophy.

    Rönnbäck C, Nissen C, Almind GJ, et al.

    Acta ophthalmologica 2015; (93(8)):762-6 doi:10.1111/aos.12835.

    PMID: 26385429
  12. 12

    Genomics combined with a protein informatics platform to assess a novel pathogenic variant c.1024 A>G (p.K342E) in OPA1 in a patient with autosomal dominant optic atrophy.

    Ahuja AS, Selvam P, Vadlamudi C, et al.

    Ophthalmic genetics 2020; (41(6)):563-569 doi:10.1080/13816810.2020.1814344.

    PMID: 32940104
  13. 13

    Preimplantation Genetic Diagnosis of Neurodegenerative Diseases: Review of Methodologies and Report of Our Experience as a Regional Reference Laboratory.

    Liao CH, Chang MY, Ma GC, et al.

    Diagnostics (Basel, Switzerland) 2019; (9(2)) doi:10.3390/diagnostics9020044.

    PMID: 31018485
  14. 14

    Clinical and genetic features of eight Chinese autosomal-dominant optic atrophy pedigrees with six novel OPA1 pathogenic variants.

    Li H, Jones EM, Li H, et al.

    Ophthalmic genetics 2018; (39(5)):569-576 doi:10.1080/13816810.2018.1466337.

    PMID: 29952689

This information about ADOA inheritance is for educational purposes only and does not replace professional medical advice. Always consult a genetic counselor or ophthalmologist to discuss your family's specific risks and testing options.

Get notified when new evidence is published on Autosomal dominant optic atrophy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.